Medicare Enrolled

Dr. Sandeep Kodityal, MD

Hematology & Oncology · Shenandoah, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
18488 INTERSTATE 45 S, Shenandoah, TX 77384
2815692100
In practice since 2007 (19 years)
NPI: 1790820736 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kodityal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kodityal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kodityal

Dr. Sandeep Kodityal is a hematology & oncology specialist in Shenandoah, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kodityal performed 50,021 Medicare services across 1,119 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kodityal received a total of $256,787 from 82 pharmaceutical and/or device companies across 1010 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kodityal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 19% volume in TX $256,787 industry payments

Medicare Practice Summary

Medicare Utilization ↗
50,021
Medicare services
Top 19% in TX for hematology & oncology
1,119
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,633 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron sucrose injection (Venofer) 31,800 $0 $1
Darbepoetin injection (Aranesp) for anemia 8,919 $2 $8
Contrast dye for imaging (iodine-based) 4,200 $0 $0
Flow cytometry, additional marker 1,991 $19 $63
Office visit, established patient (30-39 min) 832 $91 $348
Dexamethasone injection (steroid) 684 $0 $0
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 276 $22 $82
Drug injection, under skin or into muscle 217 $10 $39
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 204 $47 $179
Administration of chemotherapy into vein, 1 hour or less 202 $98 $374
Flow cytometry technique for dna or cell analysis, first marker 89 $58 $193
New patient office visit (45-59 min) 80 $118 $451
Irrigation of implanted venous access drug delivery device 77 $18 $73
Nuclear medicine study from skull base to mid-thigh with ct scan 68 $1,135 $5,267
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 63 $110 $295
Telephone medical discussion with physician, 21-30 minutes 62 $77 $345
CT scan of chest, without contrast 41 $44 $329
Hospital follow-up visit, high complexity 34 $91 $283
Ct scan of chest with contrast 33 $60 $440
Initial hospital admission, high complexity 32 $133 $504
Ct scan of abdomen and pelvis without contrast 28 $74 $452
Office visit, established patient (20-29 min) 28 $61 $246
CT scan of abdomen and pelvis with contrast 24 $168 $809
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional 21 $18 $62
Office visit, established patient, complex (40-54 min) 16 $137 $480
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
92.4% medium
6.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$256,787
Total received (2018-2024)
Avg $36,684/year across 7 years
Top 2% in TX for hematology & oncology
82
Companies
1,010
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$238,301 (92.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,637 (4.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,850 (2.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$37,281
2023
$50,525
2022
$33,277
2021
$23,219
2020
$22,349
2019
$43,986
2018
$46,150

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$102,781
Lilly USA, LLC
$89,643
Takeda Pharmaceuticals U.S.A., Inc.
$30,746
Mirati Therapeutics, Inc.
$7,715
Gilead Sciences, Inc.
$6,023
Karyopharm Therapeutics Inc.
$3,026
E.R. Squibb & Sons, L.L.C.
$2,751
PFIZER INC.
$1,861
Amgen Inc.
$1,476
Foundation Medicine, Inc.
$1,094
Astellas Pharma US Inc
$956
Novartis Pharmaceuticals Corporation
$797
Celgene Corporation
$776
Janssen Biotech, Inc.
$740
Daiichi Sankyo Inc.
$423
Seagen Inc.
$406
Merck Sharp & Dohme Corporation
$396
Alexion Pharmaceuticals, Inc.
$371
Incyte Corporation
$296
GENZYME CORPORATION
$237
BeiGene USA, Inc.
$209
GlaxoSmithKline, LLC.
$205
PharmaEssentia USA Corporation
$196
Merck Sharp & Dohme LLC
$194
Genentech USA, Inc.
$186
Adaptive Biotechnologies Corporation
$182
ASD SPECIALTY HEALTHCARE, LLC
$182
Pharmacyclics LLC, An AbbVie Company
$171
Boehringer Ingelheim Pharmaceuticals, Inc.
$157
Rigel Pharmaceuticals, Inc.
$143
ABBVIE INC.
$139
TESARO, Inc.
$136
Deciphera Pharmaceuticals Inc.
$112
Janssen Scientific Affairs, LLC
$94
Verastem, Inc.
$94
Eisai Inc.
$88
SANOFI-AVENTIS U.S. LLC
$87
Janssen Pharmaceuticals, Inc
$87
EISAI INC.
$81
MorphoSys, US Inc.
$68
Bayer HealthCare Pharmaceuticals Inc.
$67
SOBI, INC
$66
Clovis Oncology, Inc.
$64
ARRAY BIOPHARMA INC
$63
CTI BioPharma Corp.
$63
EMD Serono, Inc.
$61
Kite Pharma, Inc.
$59
PUMA BIOTECHNOLOGY, INC.
$56
Exelixis Inc.
$54
Teva Pharmaceuticals USA, Inc.
$50
Dendreon Pharmaceuticals LLC
$46
ADC Therapeutics America, Inc.
$45
Regeneron Healthcare Solutions, Inc.
$45
Puma Biotechnology, Inc.
$44
Bayer Healthcare Pharmaceuticals Inc.
$44
Ipsen Biopharmaceuticals, Inc
$42
Blueprint Medicines Corporation
$42
Seattle Genetics, Inc.
$35
Dova Pharmaceuticals
$33
Sobi, Inc
$30
Shionogi Inc
$27
TG THERAPEUTICS, INC.
$26
Myovant Sciences Inc.
$26
JAZZ PHARMACEUTICALS INC.
$26
BOSTON SCIENTIFIC CORPORATION
$25
Immunocore Limited
$25
MEDIVATION FIELD SOLUTIONS LLC
$25
Alnylam Pharmaceuticals Inc.
$23
Stemline Therapeutics Inc.
$23
SpringWorks Therapeutics, Inc.
$22
TerSera Therapeutics LLC
$22
AVEO Pharmaceuticals, Inc.
$22
Jazz Pharmaceuticals Inc.
$20
Kyowa Kirin, Inc.
$20
Spectrum Pharmaceuticals Inc.
$20
TAIHO ONCOLOGY, INC.
$19
Epizyme, Inc.,
$18
Mylan Institutional Inc.
$15
Heron Therapeutics, Inc.
$14
Taiho Oncology, Inc.
$14
Pharmacosmos Therapeutics Inc.
$12
Sirtex Medical Inc
$9
Top 3 companies account for 86.9% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AUGTYRO · AVYCAZ · AYVAKIT · Abraxane · Alecensa · Avastin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CALQUENCE · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE LIQUID · Fetroja · Folotyn · Fulphila · GILOTRIF · HYQVIA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · Monoferric · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OPDIVO · OPDUALAG · ORGOVYX · OXLUMO · Orserdu · PADCEV · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUTENT · TABRECTA · TAGRISSO · TAZVERIK · TECENTRIQ · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · ZEJULA · Zoladex · Zydelig · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for hematology & oncology in TX.

Equivalent to $513 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Shenandoah?
Compare hematology & oncology specialists in the Shenandoah area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
27
Per 100K population
4.1
County median income
$97,266
Nearest hospital
ST LUKE'S THE WOODLANDS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kodityal is a mixed practice specialist, with above-average Medicare volume (top 19% in TX), with speaking/promotional industry engagement in the top 2% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kodityal experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Kodityal performed 31,800 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kodityal receive payments from pharmaceutical companies?
Yes. Dr. Kodityal received a total of $256,787 from 82 companies across 1,010 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kodityal's costs compare to other hematology & oncology specialists in Shenandoah?
Dr. Kodityal's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kodityal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →